| [1] |
Ito T,Sasano HM,Osamura RY, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan[J]. J Gastroenterol, 2010, 45(2): 234-243.
|
| [2] |
Caplin M,Sundin A,Nillson O, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms[J]. Neuroendocrinology, 2012, 95(2): 88-97.
|
| [3] |
Yao J,Hassan MA,Dagohoy C, et al. One hundred years after ʺcarcinoidʺ: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J]. J Clini Oncol, 2008, 26(18): 3063-3072.
|
| [4] |
Modlin IM,Kidd M,Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology[J]. Gastroenterology, 2005, 128(6): 1717-1751.
|
| [5] |
Lawrence B,Gustafsson BI,Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am, 2011, 40(1): 1-18.
|
| [6] |
Panzuto F,Nasoni SM,Corleto VD, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization[J]. Endocr Relat Cancer, 2005, 12(4): 1083-1092.
|
| [7] |
Ter-Minassian M,Chan JA,Hooshmand SM, et al. Clinical Presentation, Recurrence, and Survival in Patients with Neuroendocrine Tumors: Results from a Prospective Institutional Database[J]. Endocr Relat Cancer, 2013, 20(2): 187-196.
|
| [8] |
Hainsworth JD,Spigel DR,Litchy S, et al. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study[J]. J Clini Oncol, 2006, 24(22): 3548-3554.
|
| [9] |
Landry CS,Brock G,Scoggins CR, et al. A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients[J]. Surgery, 2008, 144(3): 460-466.
|
| [10] |
Landry CS,Brock G,Scoggins CR, et al. Pproposed staging system for colon carcinoid tumors based on an analysis of 2459 patients[J]. J Am Coll Surg, 2008, 207(11): 874-881.
|